The Trump administration's deal with Intel converts $8.9 billion in CHIPS Act grants into a 10% equity stake, including a five-year warrant to prevent the company from selling or spinning off its loss-making foundry unit. This ensures U.S. control over critical chip manufacturing amid national security concerns. Critics warn of excessive government intervention in private industry.